Tag: Corrective and preventive actions GMP

How to Navigate the Regulatory Framework for GMP in European Union Member States

February 10, 2025 digi

How to Navigate the Regulatory Framework for GMP in European Union Member States Navigating GMP Regulatory Frameworks Across EU Member States: A Comprehensive Guide Introduction to GMP in the European Union The European Union (EU) enforces stringent Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and quality of pharmaceutical products. While the European Medicines…

GMP in Europe (EMA, MHRA)

How to Improve GMP Compliance in Sub-Saharan Africa’s Pharma Industry

February 10, 2025 digi

How to Improve GMP Compliance in Sub-Saharan Africa’s Pharma Industry Enhancing GMP Compliance in Sub-Saharan Africa’s Pharmaceutical Sector Introduction to GMP Compliance in Sub-Saharan Africa Sub-Saharan Africa is witnessing significant growth in its pharmaceutical sector, driven by increasing demand for locally produced medicines and efforts to reduce dependency on imports. However, achieving and maintaining Good…

GMP in Emerging Markets (GCC, Latin America, Africa)

Best Practices for Managing Raw Materials and Components for Schedule M Revised Compliance

February 10, 2025 digi

Best Practices for Managing Raw Materials and Components for Schedule M Revised Compliance Step-by-Step Guide to Managing Raw Materials and Components for Schedule M Revised Compliance Introduction to Raw Material Management and Schedule M Revised Effective management of raw materials and components is fundamental to achieving Good Manufacturing Practices (GMP) compliance in pharmaceutical manufacturing. With…

GMP in India

How GMP Ensures the Safety of Biopharmaceutical Products in Europe

February 9, 2025 digi

How GMP Ensures the Safety of Biopharmaceutical Products in Europe Understanding the Role of GMP in Ensuring the Safety of Biopharmaceuticals in Europe Introduction to GMP and Biopharmaceutical Safety Biopharmaceutical products, including vaccines, monoclonal antibodies, and cell therapies, are at the forefront of medical innovation. Their complex nature and manufacturing processes demand stringent quality control…

GMP in Europe (EMA, MHRA)

How to Build GMP-Compliant Pharmaceutical Facilities in Emerging Markets

February 9, 2025 digi

How to Build GMP-Compliant Pharmaceutical Facilities in Emerging Markets A Comprehensive Guide to Constructing GMP-Compliant Pharmaceutical Facilities in Emerging Markets Introduction to GMP Compliance for Facility Design Building Good Manufacturing Practices (GMP)-compliant pharmaceutical facilities is a critical step for manufacturers in emerging markets such as Africa, Latin America, and the Gulf Cooperation Council (GCC). GMP…

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Enhances the Quality and Consistency of Pharmaceutical Products

February 9, 2025 digi

How Schedule M Revised Enhances the Quality and Consistency of Pharmaceutical Products The Role of Schedule M Revised in Improving Pharmaceutical Product Quality and Consistency Introduction to Schedule M Revised and Product Quality Ensuring the quality and consistency of pharmaceutical products is critical for safeguarding public health. With the introduction of Schedule M Revised under…

GMP in India

How to Implement Quality Assurance Systems for GMP Compliance in European Pharma

February 9, 2025 digi

How to Implement Quality Assurance Systems for GMP Compliance in European Pharma Step-by-Step Guide to Implementing Quality Assurance Systems for GMP Compliance in Europe Introduction to Quality Assurance and GMP Compliance Quality Assurance (QA) is a cornerstone of Good Manufacturing Practices (GMP) compliance in the pharmaceutical industry. In Europe, the European Medicines Agency (EMA) sets…

GMP in Europe (EMA, MHRA)

The Role of GMP in Preventing Counterfeit Drugs in Africa and Latin America

February 9, 2025 digi

The Role of GMP in Preventing Counterfeit Drugs in Africa and Latin America How GMP Compliance Helps Combat Counterfeit Drugs in Africa and Latin America Introduction to Counterfeit Drugs and GMP Counterfeit drugs pose a significant threat to public health, particularly in Africa and Latin America, where the pharmaceutical markets are expanding rapidly. These fake…

GMP in Emerging Markets (GCC, Latin America, Africa)

How to Address Schedule M Revised Non-Compliance During GMP Audits in India

February 8, 2025 digi

How to Address Schedule M Revised Non-Compliance During GMP Audits in India A Guide to Resolving Non-Compliance Issues for Schedule M Revised GMP Audits Introduction to Schedule M Revised and GMP Audits The Schedule M Revised guidelines under the Drugs and Cosmetics Rules, 1945, have set stringent Good Manufacturing Practices (GMP) requirements for pharmaceutical manufacturers…

GMP in India

The Role of CAPA in Ensuring GMP Compliance in Europe

February 8, 2025 digi

The Role of CAPA in Ensuring GMP Compliance in Europe How to Effectively Use CAPA to Maintain GMP Compliance in Europe Introduction to CAPA and GMP Compliance Corrective and Preventive Actions (CAPA) are essential tools for maintaining Good Manufacturing Practices (GMP) compliance in the European pharmaceutical industry. CAPA systems are designed to identify, address, and…

GMP in Europe (EMA, MHRA)